This email is being sent to local health officers, tribal health directors, COVID-19 vaccinators, COVID-19 vaccine stakeholders, HERC coordinators, and key DHS staff.
Pfizer Single Dose Vials Available Next Week for Direct Ship Order Only
A limited amount of the bivalent gray cap Pfizer COVID-19 vaccine for people 12 years of age or older will be available for ordering next week in single-dose vials (SDVs). Vaccinators can place orders for Pfizer SDVs by completing the COVID-19 Vaccine Ordering Survey. This is the same process that is used to order all COVID-19 vaccines.
SDVs shipping and ordering
Due to limited quantities, the Pfizer SDVs will be available for direct ship order only. Wisconsin vaccinators can only put in one order for 50 doses, until further notice. If vaccinators want less than 50 doses, they are instructed to list the extra doses they receive on the Wisconsin COVID-19 Vaccine Exchange. At this time, this product will not be distributed from the regional distribution hubs.
SDVs storage, handling, and vials
The Pfizer SDVs have the same storage and handling requirements as with other Pfizer tris products (store at ultra-low temperature until expiry, may refrigerate up to 10 weeks within expiry period). No ancillary supplies, including COVID-19 vaccine record cards, will be provided with this SDV product. SDVs do not require low-dead-volume syringes.
The product has 1 dose per vial and 10 vials per carton. As noted previously, the only order quantity available for Wisconsin vaccinators at this time will be one order for 50 doses.
The cap colors and vial label borders for both the monovalent and bivalent Pfizer products are gray. It is important to read the label carefully to differentiate between the vaccine products to ensure people 12 years of age or older receive the appropriate vaccine.
SDVs are intended to provide greater flexibility in vaccine distribution
The limited rollout of Pfizer SDVs is intended to expand the number of locations that offer the bivalent booster vaccine. Vaccinators are encouraged to use SDVs at sites where they can increase access and availability of the bivalent booster vaccine. For example, SDVs could be used to expand access at doctors’ offices or community health centers that have consistently low or irregular patient traffic and/or might not otherwise offer the COVID-19 vaccine. The SDVs may also encourage new sites to enroll as a COVID-19 vaccinator.
|
